Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
165.1 USD | -0.79% | +2.33% | +6.50% |
May. 17 | Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target | MT |
May. 17 | ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta... |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.50% | 294B | |
+34.13% | 693B | |
+29.39% | 584B | |
-3.09% | 372B | |
+20.46% | 332B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.91% | 168B | |
-0.90% | 162B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine